Understanding the transition from psoriasis to psoriatic arthritis: the role of targeted therapy
Authors:
Open Access
- 30 December 2025
- journal article
- review article
- Published by Elsevier in EULAR Rheumatology Open
- Vol. 2 (1) , 58-61
Abstract
No abstract availableKeywords
Funding Information
- University Health Network
- University of Toronto
- Krembil Foundation
- University Health Network Foundation
This publication has 30 references indexed in Scilit:
- Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologicsAnnals of the Rheumatic Diseases, 2025
- Effect of Biological Therapy for Psoriasis on the Development of Psoriatic Arthritis: A Population-Based Cohort StudyBioDrugs, 2024
- Risk of developing inflammatory arthritis in patients with psoriasis initiating treatment with biologics: A population-based analysisJournal of the American Academy of Dermatology, 2024
- From Psoriasis to Psoriatic Arthritis: Decoding the Impact of Treatment Modalities on the Prevention of Psoriatic ArthritisRheumatology and Therapy, 2024
- Time to transition from psoriasis to psoriatic arthritis: A population-based studySeminars in Arthritis and Rheumatism, 2021
- Incidence of Psoriatic Arthritis Among Patients Receiving Biologic Treatments for Psoriasis: A Nested Case–Control StudyArthritis & Rheumatology, 2021
- The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis PathogenesisClinical Reviews in Allergy & Immunology, 2018
- The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort StudyArthritis & Rheumatology, 2015
- The Epidemiology of Psoriatic ArthritisRheumatic Disease Clinics of North America, 2015
- The problem of “protopathic bias” in case-control studiesThe American Journal of Medicine, 1980